Effects of SGLT-2 inhibitor on myocardial fibrosis and left ventricular reverse remodeling

Effects of SGLT-2 inhibitor on myocardial fibrosis and left ventricular reverse remodeling

Bibliographic Details
Main Authors:	Dipak Katare, Arun Mohanty, Vyom Mori, Rajaram Mantri
Format:	Article
Language:	English
Published:	Elsevier 2021-12-01
Series:	Indian Heart Journal
Online Access:	http://www.sciencedirect.com/science/article/pii/S0019483221004259

Similar Items

Effect of SGLT-2 inhibitor, dapagliflozin, on left ventricular remodeling in patients with type 2 diabetes and HFrEF
by: Qianyu Fu, et al.
Published: (2023-11-01)

Electrocardiographic Markers of Adverse Left Ventricular Remodeling and Myocardial Fibrosis in Severe Aortic Stenosis
by: Giedrė Balčiūnaitė, et al.
Published: (2023-08-01)

Left ventricular remodeling response to SGLT2 inhibitors in heart failure: an updated meta-analysis of randomized controlled studies
by: Erberto Carluccio, et al.
Published: (2023-09-01)

Correlation of Myocardial Native T1 and Left Ventricular Reverse Remodeling after Valvular Surgery
by: Maria von Stumm, et al.
Published: (2023-04-01)

Left ventricular remodelling in patients with reversible ischemic dysfunction before and after myocardial revascularization
by: Kh. A. Mamatkulov, et al.
Published: (1970-01-01)

Left ventricular structural heterogeneity and myocardial remodelling
by: A. M. Naidich
Published: (2006-03-01)

Left ventricular remodeling in patients with right ventricular myocardial infarction
by: M. T. Beyshenkulov,, et al.
Published: (2015-12-01)

Left ventricular remodeling in patients with right ventricular myocardial infarction
by: M. T. Beyshenkulov,, et al.
Published: (2015-12-01)

Left ventricular myocardial remodeling in playing sports athletes
by: E. V. Bryntseva
Published: (2022-08-01)

Effect of sodium-glucose cotransporter 2 (SGLT2) inhibitors on left ventricular remodelling and longitudinal strain: a prospective observational study
by: Sergio Gamaza-Chulián, et al.
Published: (2021-09-01)

Myocardial fibrosis reversion via rhACE2-electrospun fibrous patch for ventricular remodeling prevention
by: Zeping Qiu, et al.
Published: (2021-08-01)

The Rare Condition of Left Ventricular Non-Compaction and Reverse Remodeling
by: Cristiana Bustea, et al.
Published: (2023-06-01)

Plasma microRNAs in human left ventricular reverse remodelling
by: Rehan Rajan, et al.
Published: (2020-07-01)

Left ventricular myocardial remodeling in dogs with mitral valve endocardiosis
by: Yury A. Vatnikov, et al.
Published: (2020-04-01)

Association of serum ADAMTS-7 levels with left ventricular reverse remodeling after ST-elevation myocardial infarction
by: Wenjing Wu, et al.
Published: (2018-03-01)

The association of C-reactive protein with left ventricular systolic function and left ventricular myocardial fibrosis
by: Sacchi Terrence, et al.
Published: (2009-01-01)

Clinical Prognosis in Patients with Heart Failure and Reduced Left Ventricular Ejection Fraction after Myocardial Revascularization on the Background of Taking SGLT2 Inhibitors
by: Mariia V. Kucheriava, et al.
Published: (2022-06-01)

Left ventricular reverse remodelling and its predictors in non‐ischaemic cardiomyopathy
by: Tomas Hnat, et al.
Published: (2022-08-01)

Left Ventricular Remodeling after Myocardial Infarction: From Physiopathology to Treatment
by: Sabina Andreea Leancă, et al.
Published: (2022-07-01)

Are there gender differences in left ventricular remodeling after myocardial infarction in rats?
by: Ednei Luiz Antonio, et al.
Published: (2015-02-01)

Functional classification of left ventricular remodelling: prognostic relevance in myocardial infarction
by: Surenjav Chimed, et al.
Published: (2022-04-01)

PREDICTORS OF ADVERSE LEFT VENTRICULAR REMODELING IN PATIENTS AFTER MYOCARDIAL INFARCTION
by: E S Zharikova, et al.
Published: (2017-12-01)

Circulating biomarkers as predictors of left ventricular remodeling after myocardial infarction
by: Michał Węgiel, et al.
Published: (2021-03-01)

Predictors of Left Ventricular Remodeling after Revascularized Acute Myocardial Infarction
by: Pop Sorin, et al.
Published: (2016-06-01)

Effects of SGLT2 Inhibitors beyond Glycemic Control—Focus on Myocardial SGLT1
by: Alex Ali Sayour, et al.
Published: (2021-09-01)

Factors associated with left ventricular reverse remodelling after percutaneous coronary intervention in patients with left ventricular systolic dysfunction
by: Yusuke Adachi, et al.
Published: (2021-01-01)

Prognostic importance of glycemic variability on left ventricular reverse remodeling after the first episode of ST-segment elevation myocardial infarction
by: Yohei Hanajima, et al.
Published: (2023-08-01)

Comparison of the Reverse-Remodeling Effect of Pharmacological Soluble Guanylate Cyclase Activation With Pressure Unloading in Pathological Myocardial Left Ventricular Hypertrophy
by: Mihály Ruppert, et al.
Published: (2019-01-01)

Left ventricular mass predicts cardiac reverse remodelling in patients treated with empagliflozin
by: Pankaj Puar, et al.
Published: (2023-06-01)

MitraClip and left ventricular reverse remodelling: a strain imaging study
by: Konstantinos Papadopoulos, et al.
Published: (2020-08-01)

Is longitudinal strain associated with left ventricular remodeling in patients with acute myocardial infarction?
by: Papadopoulos, C, et al.
Published: (2008)

Ischaemic preconditioning prevents left ventricular remodelling in patients with acute myocardial infarction
by: Papadopoulos, C, et al.
Published: (2005)

The Role of Ferroptosis in Adverse Left Ventricular Remodeling Following Acute Myocardial Infarction
by: Kyoko Komai, et al.
Published: (2022-04-01)

Prevention of left ventricular remodeling after myocardial infarction: efficacy of physical training
by: Camillo Taglieri, et al.
Published: (2016-01-01)

Plasma Circulating Extracellular RNAs in Left Ventricular Remodeling Post-Myocardial Infarction
by: Kirsty M. Danielson, et al.
Published: (2018-06-01)

Diffuse Myocardial Fibrosis Reduces Electrocardiographic Voltage Measures of Left Ventricular Hypertrophy Independent of Left Ventricular Mass
by: Maren Maanja, et al.
Published: (2017-01-01)

Characterization of heart failure patients with reverse left ventricular remodelling post‐angiotensin receptor blockers/neprilysin inhibitors therapy
by: Leonid Maizels, et al.
Published: (2022-06-01)

Imaging, biomarker and invasive assessment of diffuse left ventricular myocardial fibrosis in atrial fibrillation
by: Gordon A. Begg, et al.
Published: (2020-02-01)

The predictive value of coronary microvascular dysfunction for left ventricular reverse remodelling in dilated cardiomyopathy
by: Ao Kan, et al.
Published: (2023-12-01)

The potential predictive value of cardiac mechanics for left ventricular reverse remodelling in dilated cardiomyopathy
by: Ao Kan, et al.
Published: (2023-12-01)